LON:DOCS Dr. Martens (DOCS) Share Price, News & Analysis → [Shocking] Elon Musk’s Plan To End Banks (From Crypto 101 Media) (Ad) Free DOCS Stock Alerts GBX 72.10 +4.80 (+7.13%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range 69.20▼ 73.1850-Day Range 67▼ 97.8052-Week Range 62▼ 174.70Volume3.53 million shsAverage Volume1.56 million shsMarket Capitalization£693.49 millionP/E Ratio721.00Dividend Yield8.32%Price TargetGBX 177.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get Dr. Martens alerts: Email Address Dr. Martens MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside146.2% UpsideGBX 177.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment-0.10Based on 12 Articles This WeekInsider TradingAcquiring Shares£44,906 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.86 out of 5 stars 3.3 Analyst's Opinion Consensus RatingDr. Martens has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDr. Martens has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 1.7 Dividend Strength Dividend LeadershipDr. Martens is a leading dividend payer. It pays a dividend yield of 6.58%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthDr. Martens does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Dr. Martens is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 1.1 News and Social Media Coverage News SentimentDr. Martens has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Dr. Martens this week, compared to 2 articles on an average week.Search InterestOnly 6 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Dr. Martens to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £449.06 in company stock and sold GBX 0 in company stock.Percentage Held by InsidersOnly 4.12% of the stock of Dr. Martens is held by insiders.Percentage Held by Institutions73.65% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Dr. Martens is 721.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 143.00.Price to Earnings Ratio vs. SectorThe P/E ratio of Dr. Martens is 721.00, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 320.45.Price to Earnings Growth RatioDr. Martens has a PEG Ratio of 2.70. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDr. Martens has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Dr. Martens Stock (LON:DOCS)Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.Read More DOCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesApril 13, 2024 | insidertrades.comDr. Martens plc (LON:DOCS) Insider Jon Mortimore Acquires 159 SharesApril 18, 2024 | msn.comSave up to 75% on Dr. Martens at Nordstrom Rack’s Flash sale this week onlyApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 17, 2024 | msn.comGen Z favorite Dr. Martens is struggling as its CEO steps down—and it might be because their shoes last too longApril 17, 2024 | theguardian.comDr Martens investors should be kicking themselvesApril 16, 2024 | msn.comDr. Martens’ profit warning highlights U.S. consumer-confidence challengeApril 16, 2024 | finance.yahoo.comDr. Martens shares plunge to record low after weak US revenue outlookApril 16, 2024 | msn.comBootmaker Dr Martens names new CEO, flags tough year on weak demandApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 16, 2024 | msn.com'No blister' Dr Martens boots in six colours that are a 'lifelong love' just £80 in saleApril 16, 2024 | markets.businessinsider.comDr. Martens Sees Annual Result In Line With Guidance; Says 2025 Outlook ChallengingApril 16, 2024 | finance.yahoo.comDr. Martens Shares Tumble as Bootmaker Warns of Tough YearApril 16, 2024 | uk.finance.yahoo.comDr Martens shares dive to record low after profit warning and chief’s exitApril 16, 2024 | finance.yahoo.comDr. Martens Stock Plunges on Profit Warning, CEO ExitApril 16, 2024 | americanbankingnews.comDr. Martens (LON:DOCS) Sets New 52-Week Low at $65.50April 14, 2024 | yahoo.comGwen Stefani Wears Sparkling Dr. Martens and Reunites With No Doubt at CoachellaApril 14, 2024 | finance.yahoo.comUnder The Bonnet, Dr. Martens' (LON:DOCS) Returns Look ImpressiveApril 10, 2024 | msn.comOlivia Rodrigo Casts Her Vote for 2024's It-SneakerApril 10, 2024 | msn.comThe Olivia Rodrigo Guide to Girl-Power MenswearApril 9, 2024 | msn.comHere’s Why More Shoe Brands Like Dr. Martens and New Balance Are Opting for Resale ProgramsApril 9, 2024 | axios.comMulti-brand buyer fits Dr. Martens bestApril 8, 2024 | msn.comOlivia Rodrigo and Conan Gray Coordinate in Dr. Martens Shoes While Out in NYCApril 5, 2024 | msn.comThese TikTok-Famous Dr. Martens Mary Jane Shoes Easily Add Some Cool-Girl Edge to Your Feminine Spring Style - And They're 40% Off TodayApril 4, 2024 | msn.comThe 7 Very Best Dr. Martens to Buy, As Told By Serial Docs WearersApril 3, 2024 | thetimes.co.ukDr Martens feels heat from New York activist investorApril 2, 2024 | msn.comDr Marten's sale sees 'classic' £169 boots that are 'made to last' slashed to under £76April 2, 2024 | msn.comWill the stock market crash in 2024?See More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 2/2 Dividend1/04/2024Dividend Payable2/02/2024Today4/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryN/A Current SymbolLON:DOCS CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees2,591Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 177.50 High Stock Price TargetGBX 180 Low Stock Price TargetGBX 175 Potential Upside/Downside+146.2%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.10 Trailing P/E Ratio721.00 Forward P/E Ratio8.13 P/E Growth2.7Net Income£103.20 million Net Margins10.56% Pretax MarginN/A Return on Equity29.07% Return on Assets10.31% Debt Debt-to-Equity Ratio143.48 Current Ratio2.44 Quick Ratio1.13 Sales & Book Value Annual Sales£977.50 million Price / Sales0.71 Cash FlowGBX 5.05 per share Price / Cash Flow14.29 Book ValueGBX 37 per share Price / Book1.95Miscellaneous Outstanding Shares961,850,000Free FloatN/AMarket Cap£693.49 million OptionableNot Optionable Beta-0.02 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Kenneth Wilson (Age 58)CEO & Director Comp: $773kMr. Jon William Mortimore (Age 57)CFO & Director Comp: $503kMr. Onyeije Ogueri Nwokorie (Age 54)Chief Brand Officer Comp: $67kMr. Geert Peeters (Age 58)Chief Operating Officer Mr. Ronald GarricksChief Information OfficerMs. Meg JohnsonChief Marketing OfficerMs. Emily Clare Reichwald (Age 49)Chief People & Sustainability Officer and Company Secretary Mr. Sean O'NeillChief Digital OfficerMr. Derek ChanPresident of APACMr. Adam M. MeekChief Product OfficerMore ExecutivesKey CompetitorsMcCarthy & StoneLON:MCSPendragonLON:PDGPPHE Hotel GroupLON:PPHCVS GroupLON:CVSGPinewood Technologies GroupLON:PINEView All CompetitorsInsidersJon MortimoreBought 159 shares on 4/11/2024Total: £14,946.00 ($94.00/share)Kenny WilsonBought 163 shares on 3/11/2024Total: £14,996.00 ($92.00/share)Kenny WilsonBought 172 shares on 2/12/2024Total: £14,964.00 ($87.00/share)Jon MortimoreBought 185 shares on 1/11/2024Total: £14,985.00 ($81.00/share)Kenny WilsonBought 164 shares on 12/11/2023Total: £14,924.00 ($91.00/share)View All Insider Transactions DOCS Stock Analysis - Frequently Asked Questions Should I buy or sell Dr. Martens stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DOCS shares. View DOCS analyst ratings or view top-rated stocks. What is Dr. Martens' stock price target for 2024? 2 brokerages have issued 12-month target prices for Dr. Martens' stock. Their DOCS share price targets range from GBX 175 to GBX 180. On average, they predict the company's share price to reach GBX 177.50 in the next twelve months. This suggests a possible upside of 146.2% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2024? Dr. Martens' stock was trading at GBX 88.60 on January 1st, 2024. Since then, DOCS shares have decreased by 18.6% and is now trading at GBX 72.10. View the best growth stocks for 2024 here. How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens? Dr. Martens declared a dividend on Saturday, November 30th. Shareholders of record on Thursday, January 4th will be given a dividend of GBX 1.56 per share on Friday, February 2nd. This represents a yield of 1.36%. The ex-dividend date of this dividend is Thursday, January 4th. The official announcement can be accessed at this link. Read our dividend analysis for DOCS. Is Dr. Martens a good dividend stock? Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 6.58%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for DOCS. How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:DOCS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
